KATIE YEATON: Open Payments
NPI 1205358892 · BALLSTON SPA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,042 in 41 payments from 10 companies in 2025. Trend: 2023 $1,722 · 2024 $1,794 · 2025 $1,042
Food & beverage: $1,042
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $377 |
| Abbott Laboratories | 2 | $212 |
| ABBVIE INC. | 8 | $137 |
| GlaxoSmithKline, LLC. | 5 | $90 |
| Lilly USA, LLC | 3 | $62 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
| PFIZER INC. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| IBSA Pharma Inc. | 1 | $14 |
Products named: Ozempic, FREESTYLE LIBRE 3, Wegovy, QULIPTA, TRELEGY ELLIPTA, UBRELVY, MOUNJARO, GEMTESA.
Industry payments across NY — which companies pay providers there.
